Skip to main content

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

GILD holding history

Gilead Sciences, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GILD overviewAll 13F holders of GILDFull Q2 2026 holdings

Shares (Q2 2026)
5,113,242
Value
$646.0M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of GILD by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,113,242$646.0M0.2%−168,954−3.2%ReducedHolders
Q1 20265,282,196$736.2M0.3%−3,833,287−42.1%ReducedHolders
Q4 20259,115,483$1.12B0.4%+3,942,335+76.2%AddedHolders
Q3 20255,173,148$574.2M0.2%−923,527−15.1%ReducedHolders
Q2 20256,096,675$675.9M0.3%+492,410+8.8%AddedHolders
Q1 20255,604,265$628.0M0.3%+1,204,178+27.4%AddedHolders
Q4 20244,400,087$406.4M0.2%+171,289+4.1%AddedHolders
Q3 20244,228,798$354.5M0.2%−427,594−9.2%ReducedHolders
Q2 20244,656,392$319.5M0.1%−2,151,007−31.6%ReducedHolders
Q1 20246,807,399$498.6M0.2%+1,127,429+19.8%AddedHolders
Q4 20235,679,970$460.1M0.2%+1,859,883+48.7%AddedHolders
Q3 20233,820,087$286.3M0.2%−2,822,823−42.5%ReducedHolders
Q2 20236,642,910$512.0M0.3%+2,126,182+47.1%AddedHolders
Q1 20234,516,728$374.8M0.4%−1,470,740−24.6%ReducedHolders
Q4 20225,987,468$514.0M0.4%+4,138,589+223.8%AddedHolders
Q3 20221,848,879$114.1M0.1%−293,188−13.7%ReducedHolders
Q2 20222,142,067$132.4M0.1%−778,053−26.6%ReducedHolders
Q1 20222,920,120$173.6M0.1%−2,440,498−45.5%ReducedHolders
Q4 20215,360,618$389.2M0.2%+2,272,720+73.6%AddedHolders
Q3 20213,087,898$215.7M0.2%+396,577+14.7%AddedHolders
Q2 20212,691,321$185.3M0.2%+44,088+1.7%AddedHolders
Q1 20212,647,233$171.1M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.